USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock
19.63 USD
-0.26 (-1.31%)
19.63 USD
0 (0%)
Overall USNA gets a fundamental rating of 6 out of 10. We evaluated USNA against 36 industry peers in the Personal Care Products industry. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. USNA has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
USNA had positive earnings in the past year.
USNA had a positive operating cash flow in the past year.
USNA had positive earnings in each of the past 5 years.
Each year in the past 5 years USNA had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.34%, USNA perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
With a decent Return On Equity value of 3.22%, USNA is doing good in the industry, outperforming 63.89% of the companies in the same industry.
USNA has a Return On Invested Capital of 4.04%. This is comparable to the rest of the industry: USNA outperforms 52.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.83%.
The last Return On Invested Capital (4.04%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 4.04% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
USNA's Profit Margin of 1.86% is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
In the last couple of years the Profit Margin of USNA has declined.
USNA has a Operating Margin of 4.58%. This is comparable to the rest of the industry: USNA outperforms 52.78% of its industry peers.
USNA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 79.18%, USNA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
Compared to 1 year ago, USNA has less shares outstanding
Compared to 5 years ago, USNA has less shares outstanding
Compared to 1 year ago, USNA has a worse debt to assets ratio.
2.2 Solvency
USNA has an Altman-Z score of 3.67. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
USNA's Altman-Z score of 3.67 is fine compared to the rest of the industry. USNA outperforms 72.22% of its industry peers.
USNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.67 |
ROIC/WACC0.47
WACC8.55%
2.3 Liquidity
USNA has a Current Ratio of 2.23. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
USNA has a Current ratio of 2.23. This is comparable to the rest of the industry: USNA outperforms 58.33% of its industry peers.
A Quick Ratio of 1.46 indicates that USNA should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.46, USNA is doing good in the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. Growth
3.1 Past
USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.74%.
USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.07% yearly.
USNA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.88%.
USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.23% yearly.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
3.2 Future
Based on estimates for the next years, USNA will show a small growth in Earnings Per Share. The EPS will grow by 2.69% on average per year.
USNA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y-32.13%
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue Next Year8.25%
Revenue Next 2Y3.22%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.02, the valuation of USNA can be described as very reasonable.
USNA's Price/Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 86.11% of the companies in the same industry.
USNA is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.13 indicates a reasonable valuation of USNA.
Based on the Price/Forward Earnings ratio, USNA is valued cheaper than 83.33% of the companies in the same industry.
USNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.02 | ||
| Fwd PE | 10.13 |
4.2 Price Multiples
USNA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. USNA is cheaper than 97.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.33 |
4.3 Compensation for Growth
USNA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
19.63
-0.26 (-1.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners62%
Inst Owner Change0.66%
Ins Owners0.62%
Ins Owner Change0.02%
Market Cap358.84M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (102.65%)
Short Float %5.61%
Short Ratio2.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)-36.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.97%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-9.87%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-3.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.02 | ||
| Fwd PE | 10.13 | ||
| P/S | 0.39 | ||
| P/FCF | N/A | ||
| P/OCF | 11.38 | ||
| P/B | 0.68 | ||
| P/tB | 1.46 | ||
| EV/EBITDA | 3.33 |
EPS(TTM)1.96
EY9.98%
EPS(NY)1.94
Fwd EY9.87%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY8.79%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 4.04% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 13.62% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.67 |
F-Score5
WACC8.55%
ROIC/WACC0.47
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-32.13%
EPS Next 2Y-13.66%
EPS Next 3Y2.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.25%
Revenue Next 2Y3.22%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year36.41%
EBIT Next 3Y21.21%
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 6 / 10 to USNA.
Can you provide the valuation status for USANA HEALTH SCIENCES INC?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.
What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.
Can you provide the expected EPS growth for USNA stock?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -32.13% in the next year.